All News

No clinical or genetic markers were found to be predictive of psoriatic arthritis in patients with psoriasis, but one laboratory marker was identified.

According to this retrospective analysis of preexposure prophylaxis (PrEP) utilization rates in the United States, fewer than 20% of indicated users are taking the HIV preventive medication.

Touching one’s face can heighten infection risk, but it may also help protect the body by fostering microbial diversity, according to a recent study.

Exome sequencing of patients with kidney disease and their families identified 17 different monogenetic causes of kidney disease.

The CDC issues updated mask guidance for teachers and students in school buildings; alcohol abuse is on the rise; Anthony Fauci, MD, addresses concerns on the lack of full approval for COVID-19 vaccines.

Medication adherence is crucial for managing chronic diseases, especially in complex, high-risk patients. Compliance packaging is a key tool for managing these populations.

Patients with prediabetes are at significantly higher risk of major cardiovascular events than those who have never had high blood sugar.

A look into vaccine engagement strategies among employers, and how education, incentives, and personalized experiences from employees can play a role in promoting adherence and safety.

The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates for the therapy.

A new study says that treating iron deficiency therapy may improve outcomes in patients with chronic kidney disease, even if they don’t have anemia.

In a recent review, researchers describe what is currently known about allogenic hemopoietic stem cell transplant (HSCT) for myelofibrosis.

Hormonal contraceptive use among women of childbearing age was associated with a more than 2-fold higher risk of developing glaucoma, although risk was still relatively low.

As COVID-19 cases skyrocketed in the United States throughout the pandemic, incidences of other respiratory viral infections dramatically declined.

The new report may help explain why patients with psoriasis have a higher risk of cardiovascular problems.

Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy.

David McIntyre, MD, FRACP, describes different methods of diagnosing gestational diabetes around the world.

PBMs keep copays higher on the same generic drugs.

Introducing more n-3 acids into one’s diet can mitigate headache pain for migraineurs.

New research based on real-world data largely aligns with the scientific literature, although one monoclonal antibody—dupilumab—stood out for its very low risk.

However, researchers also noted that similar to chimeric antigen receptor (CAR) T-cell therapy, CAR-NK cell treatment comes with its own set of challenges.

A new review shows secukinumab continued to have a strong safety profile after 6 years on the market.

Gary Lyman, MD, MPH, an oncologist and hematologist, discusses how biosimilars have fared in the oncology space compared to other therapeutic areas.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Considerable evidence shows sodium-glucose co-transporter-2 inhibitors have cardioprotective benefits, but new research elucidates the ways in which the drugs can also have positive renal impacts.

Pfizer and BioNTech said they will seek approval for a booster shot of their COVID-19 mRNA vaccine, while US health authorities said a booster is not necessary. In addition, the CDC emphasized in-person learning for schools this fall in updated guidance.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

President Joe Biden is expected to sign an executive order aimed at lowering drug prices; the FDA imposes limits on who should receive a controversial new Alzheimer disease drug; western US states prepare for a second heat wave.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.